Should patients with Dukes' C colon cancer receive adjuvant chemotherapy after curative resection? (Q43409216)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1825269%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

meta-analysis

0 references

title

Should patients with Dukes' C colon cancer receive adjuvant chemotherapy after curative resection? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1825269%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

3 December 2022

author name string

K. W. Tiver

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1825269

3 December 2022

A. O. Langlands

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1825269

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1825269

3 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1825269%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-2197.1991.tb00118.x

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-2197.1991.tb00118.x/fullpdf

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

3 December 2022

published in

ANZ Journal of Surgery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1825269%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1825269%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1825269%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

7-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1825269%20AND%20SRC:MED&resulttype=core&format=json

Does adjuvant therapy work in colon cancer?

18 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

FUDR as an adjuvant to surgery in cancer of the large bowel

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Adjuvant chemotherapy in the surgical treatment of large bowel cancer

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Adjuvant therapy for large bowel cancer: update of Veterans Administration Surgical Oncology Group Trials.

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Adjuvant Chemotherapy in Cancer of the Colon and Rectum: Demonstration of Effectiveness of Prolonged 5-FU Chemotherapy in a Prospectively Controlled, Randomized Trial

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time.

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Fluorouracil in chemoprophylaxis of colorectal cancer. Results of a controlled clinical trial

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Chemotherapy as an adjuvant to surgery for colorectal cancer. A follow-up report

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Adjuvant Therapy of Colon Cancer — Results of a Prospectively Randomized Trial

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Effect of adjuvant chemo- or immunotherapy on the prognosis of colorectal cancer operated for cure

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group Trial

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial

3 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure

3 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Post-operative thoracic irradiation with or without levamisole in non-small cell lung cancer: results of a Radiation Therapy Oncology Group Study

3 December 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

Status of adjuvant therapy for colorectal cancer

3 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1445-2197.1991.TB00118.X

3 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1825269%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference